MGMT and central nervous system cancer: We noticed that O-methylguanine-DNA methyltransferase (MGMT) is an important biomarker for the chemosensitivity of gliomas, and methylation detection (not IHC) is more precise for the clinical testing of MGMT in glioma patients [1, 33, 34].